Goldman Likes These 3 Stocks

  • May 25, 2005
  • Brice Wightman

Stocks are lower Wednesday as oil climbs over $50.

New home sales for April rose +0.2% to 1.316 million units…record highs but
below estimates. April durable goods orders rose +1.9%; ex transportation, -0.2%
March was revised to -1.6%. The homebuilders are weak on the March home sales
revision.

Crude oil inventories fell 1.6 million barrels–traders were expecting a
build. Gas inventories rose +0.6 million barrels.

Goldman reiterated its outperform rating on Google
(
GOOG |
Quote |
Chart |
News |
PowerRating),
Yahoo
(
YHOO |
Quote |
Chart |
News |
PowerRating) and Ebay
(
EBAY |
Quote |
Chart |
News |
PowerRating). Separately, JP Morgan raised
estimates on Google.

Visteon
(
VC |
Quote |
Chart |
News |
PowerRating) is restructuring as part of a deal with Ford. The
stock is higher pre-open.

Autozone
(
AZO |
Quote |
Chart |
News |
PowerRating) beat by 0.06; sales, however, were weaker than
expected.

Strong sectors are:  Oil Services
(
$OSX.X |
Quote |
Chart |
News |
PowerRating) +1.91%    
Oil
(
$XOI.X |
Quote |
Chart |
News |
PowerRating) +0.85%  Natural Gas
(
$XNG.X |
Quote |
Chart |
News |
PowerRating)
+0.30%      

Weak sectors are:   Chemicals
(
$CEX.X |
Quote |
Chart |
News |
PowerRating) -1.54%  Semis
(
$SOX.X |
Quote |
Chart |
News |
PowerRating)
-1.46%   Biotech  
(
$BTK.X |
Quote |
Chart |
News |
PowerRating)
-1.17%

Dow -63.18 10,440.50
Nasdaq -16.96 2044.66
S&P 500 -6.58 1187.49

The dollar is -0.05 at
86.32

Crude Oil is +1.18 at
50.85

Gold is -0.10 at 417.90

ce=”Arial” size=”2″ face=”Arial”>Volume is 710 million on the NYSE and
665 million on the Nasdaq.

Market breadth is negative.

NYSE Issues
Advancing 897 Up Vol 206
Declining 2176 Down Vol 432
2.42 2.09
Nasdaq
Advancing 841 Up Vol 168
Declining 1974 Down Vol 453
2.34 2.69

Stocks in the News

Computer Sciences
(
CSC |
Quote |
Chart |
News |
PowerRating) beat by 0.02 and raised 2006 guidance.

Echostar
(
DISH |
Quote |
Chart |
News |
PowerRating) was cut to ‘neutral’ at Bank of America.

UBS cut Genzyme
(
GENZ |
Quote |
Chart |
News |
PowerRating) to ‘neutral.’

Calpine
(
CPN |
Quote |
Chart |
News |
PowerRating) is restructuring; the stock is higher pre-open.

Encysive
(
ENCY |
Quote |
Chart |
News |
PowerRating) received an FDA application for PAH.

Medtronic
(
MDT |
Quote |
Chart |
News |
PowerRating) was in-line but light on revenues. 

Boston Scientific
(
BSX |
Quote |
Chart |
News |
PowerRating) lowered guidance, citing acquisitions and
updated expectations for the Taxus stent.

Network Appliance
(
NTAP |
Quote |
Chart |
News |
PowerRating) was in-line and announced a $300 share
repurchase program.

Brice Wightman

 

 

 

Â